Technical Analysis for ICLR - ICON plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
20 DMA Resistance | Bearish | 2.64% | |
Calm After Storm | Range Contraction | 2.64% | |
Multiple of Ten Bullish | Other | 2.64% | |
Outside Day | Range Expansion | 2.64% | |
20 DMA Resistance | Bearish | 2.46% | |
Calm After Storm | Range Contraction | 2.46% |
Alert | Time |
---|---|
Up 3% | 1 day ago |
Possible NR7 | 1 day ago |
60 Minute Opening Range Breakout | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Up 2% | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 04/26/2024
ICON plc Description
ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. It operates through two segments, Clinical Research and Central Laboratory. The Clinical Research segment specializes in strategic development, management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies. Its clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. This segment's clinical research services also comprise marker access and commercialization services, strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, pricing and market access consulting, medical imaging, contract staffing, and electronic endpoint adjudication. The Central Laboratory segment offers various laboratory services, such as sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Biology Clinical Development Pharmacology Clinical Research Clinical Trial Biomarkers Medical Imaging Medical Research Recruitment Data Collection Microbiology Laboratory Services Clinical Pharmacology Immunoassay Contract Research Organizations Flow Cytometry Interactive Voice Response Patient Safety Health Economics Statistical Analysis Clinical Data Management Contract Research Organization
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 344.77 |
52 Week Low | 185.28 |
Average Volume | 531,731 |
200-Day Moving Average | 274.62 |
50-Day Moving Average | 319.03 |
20-Day Moving Average | 303.61 |
10-Day Moving Average | 303.59 |
Average True Range | 9.68 |
RSI (14) | 51.22 |
ADX | 25.31 |
+DI | 15.05 |
-DI | 19.99 |
Chandelier Exit (Long, 3 ATRs) | 296.88 |
Chandelier Exit (Short, 3 ATRs) | 316.05 |
Upper Bollinger Bands | 320.97 |
Lower Bollinger Band | 286.24 |
Percent B (%b) | 0.66 |
BandWidth | 11.44 |
MACD Line | -3.52 |
MACD Signal Line | -4.52 |
MACD Histogram | 0.9952 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 319.81 | ||||
Resistance 3 (R3) | 319.08 | 314.75 | 318.01 | ||
Resistance 2 (R2) | 314.75 | 312.00 | 315.12 | 317.41 | |
Resistance 1 (R1) | 311.89 | 310.31 | 313.32 | 312.62 | 316.81 |
Pivot Point | 307.56 | 307.56 | 308.28 | 307.92 | 307.56 |
Support 1 (S1) | 304.69 | 304.81 | 306.13 | 305.42 | 301.23 |
Support 2 (S2) | 300.36 | 303.11 | 300.73 | 300.63 | |
Support 3 (S3) | 297.50 | 300.36 | 300.03 | ||
Support 4 (S4) | 298.23 |